Welcome to our dedicated page for Fabrinet SEC filings (Ticker: FN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fabrinet (NYSE: FN) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of its regulatory record. As a Cayman Islands–incorporated issuer with operations in Thailand, the United States, the People’s Republic of China, and Israel, Fabrinet files detailed reports that explain its financial performance, governance practices, and executive compensation programs.
Through its annual reports on Form 10-K, Fabrinet presents audited financial statements, management’s discussion and analysis, and risk factor disclosures. These documents describe revenue trends across markets such as optical communications, automotive components, industrial lasers, medical devices, and sensors, as well as information on gross margins, operating margins, cash flows, and capital investments in manufacturing facilities and equipment.
Quarterly updates, often furnished via Form 8-K with attached earnings press releases, provide interim financial results and commentary from management. Fabrinet also uses Form 8-K to report material events such as leadership changes, board appointments and retirements, and the adoption of executive incentive plans and equity awards.
The company’s definitive proxy statement on Schedule 14A offers additional insight into corporate governance, including board structure, ESG practices and policies, director and executive compensation, and matters presented for shareholder vote at the Annual General Meeting. It details items such as the election of directors, ratification of the independent auditor, and advisory votes on named executive officer compensation.
On Stock Titan, Fabrinet’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain lengthy documents like the 10-K and proxy statement by highlighting key metrics, governance decisions, compensation structures, and risk discussions. Investors can also review Form 4 and other ownership-related filings to monitor insider transactions and equity awards, using the platform’s tools to quickly understand how these regulatory disclosures relate to Fabrinet’s broader financial and operational profile.
Fabrinet appointed Caroline Dowling to its Board as a Class I director on October 13, 2025. Her term runs until the next annual meeting and continues until a successor is elected and qualified or earlier departure. She was not appointed to any Board committees.
Dowling brings extensive global manufacturing and technology-sector experience, including over 20 years at Flex, where she served as Business Group President from 2012 to 2019. She serves on the boards of CRH plc and DCC plc, and previously served on the board of IMI plc from November 2019 to May 2025. She will be compensated under Fabrinet’s standard non‑employee director policy and will enter into the company’s standard indemnification agreement. Fabrinet issued a press release on October 16, 2025 announcing the appointment.
Darlene S. Knight, a director of Fabrinet (FN), reported a sale of company stock. The Form 4 shows she disposed of 479 ordinary shares in a transaction dated 09/05/2025 at a reported price of $366 per share, leaving her with 3,684 shares beneficially owned following the sale. The filing was submitted by an attorney-in-fact on her behalf.
Fabrinet (FN) director Thomas F. Kelly reported a sale of company stock. The Form 4 shows a transaction dated 09/05/2025 in which 480 ordinary shares were disposed of at a price of $0 reported (code G). After the reported sale, Mr. Kelly beneficially owned 20,989 shares. The filing was signed by Andrew Chew as attorney-in-fact on 09/08/2025.
Form 144 notice by an individual related to Fabrinet (FN). The filer intends to sell 479 ordinary shares on 09/05/2025 through Citigroup Global Markets, with an aggregate market value of $175,314. The shares were acquired on 01/02/2024 by restricted stock vesting from Fabrinet and payment is noted as services rendered. The filing lists 35,728,074 shares outstanding for the class and identifies the NYSE as the exchange. The filer previously sold 1,200 shares on 08/27/2025 for $402,150. The notice contains the standard certification that the seller is not aware of undisclosed material adverse information.
Fabrinet (FN) Form 4: Harpal Gill, who serves as President & COO and a director, reported a sale of 14,203 ordinary shares on 09/04/2025 at a weighted average price of $355.147 per share (range $355.00 to $355.81). After the transaction Mr. Gill beneficially owned 13,983 shares. The filing was signed by an attorney-in-fact on behalf of Mr. Gill.
The form discloses the exact number of shares sold, the weighted average sale price, and the remaining beneficial ownership. No derivative transactions or amendments are reported.
Fabrinet (FN) reporting person Edward T. Archer, EVP Sales & Marketing, disclosed insider sales on 09/04/2025. The Form 4 shows three separate dispositions of ordinary shares: 1,300 shares sold at a weighted average price of $353.676, 1,533 shares sold at a weighted average price of $354.88, and 500 shares sold at a weighted average price of $355.327. The report lists sequential beneficial ownership after each sale of 8,677 shares, 7,144 shares, and 6,644 shares respectively, indicating a total of 3,333 shares disposed on that date. The filing includes explanatory notes that the reported prices are weighted averages over small price ranges and states that full per-price details will be provided upon request.
Form 144 notice for Fabrinet (FN) reports the proposed sale of 14,203 ordinary shares, with an aggregate market value of $5,042,065.00, through Citigroup Global Markets on the NYSE. The shares originated from a restricted stock vesting attributable to Fabrinet on 09/04/2025 and payment is listed as services rendered. The filing also discloses that Harpal Gill sold 18,675 ordinary shares on 06/04/2025 for gross proceeds of $4,482,018.00. The notice includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.
Fabrinet (FN) Form 144 notice reports a proposed sale of 3,333 ordinary shares through Citigroup Global Markets, Inc. on 09/04/2025 with an aggregate market value of $1,181,148.54. The filing states these shares were recorded as acquired in a Vested Share Account on 09/04/2025 and the payment type is noted as compensation. The filer also disclosed a recent sale on 08/29/2025 of 3,200 shares for gross proceeds of $1,069,440.00. By signing, the person represents no undisclosed material adverse information about the issuer.
Fabrinet director Rollance E. Olson reported two open-market dispositions of ordinary shares, selling 8,700 shares and 300 shares on 09/02/2025 at weighted average prices of approximately $334.107 and $334.565 per share, respectively. Following those transactions the reported beneficial ownership decreased to 14,501 shares after the larger sale and to 14,201 shares after the second sale. The filing includes explanatory notes that the sale prices are weighted averages across narrow price ranges and that detailed per-price quantities are available on request.
Edward T. Archer, EVP Sales & Marketing of Fabrinet (FN), reported two open-market sales on 08/29/2025. The Form 4 shows a sale of 2,325 ordinary shares at a weighted average price of $334.984 (range $334.20–$335.155) and a sale of 875 ordinary shares at a weighted average price of $335.536 (range $335.21–$336.086). The filings report the number of shares beneficially owned following the transactions as 10,852 and 9,977 respectively. The Form was signed by an attorney-in-fact on 09/02/2025.